Related Experiment Video

Updated: Sep 24, 2026

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

[Studies on molecular mechanism of toxicity of anticancer drugs]

Tsutomu Takahashi1

  • 1Laboratory of Molecular and Biochemical Toxicology, Graduate School of Pharmaceutical Sciences, Tohoku University. ttsutomu@mail.pharm.tohoku.ac.jp

Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|March 5, 2011
PubMed

Insights

Overexpression of the protein kinase Akl1 (and its human homologue AAK1) confers resistance to the anticancer drug adriamycin by downregulating endocytosis, a finding relevant for improving chemotherapy.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Anticancer drug efficacy is limited by toxicity and tumor resistance.
  • Mechanisms of anticancer drug toxicity are not fully understood.
  • Adriamycin (an anthracycline antibiotic) is a key chemotherapy agent.

Purpose of the Study:

  • To identify determinants of sensitivity to adriamycin using yeast as a model.
  • To elucidate the mechanisms underlying adriamycin toxicity and resistance.

Main Methods:

  • Conducted a genetic screen in budding yeast to identify genes affecting adriamycin sensitivity.
  • Investigated the function of the protein kinase Akl1 in adriamycin resistance.
  • Examined the effect of Akl1 and its human homologue AAK1 on adriamycin toxicity in human cells.

Main Results:

  • Overexpression of Akl1 conferred resistance to adriamycin in yeast.
  • Akl1's function in downregulating endocytosis internalization is linked to adriamycin resistance.
  • Overexpression of human AAK1 also decreased adriamycin toxicity, suggesting conserved mechanisms.

Conclusions:

  • Downregulation of endocytosis, potentially via phosphorylation by AAK1, is involved in adriamycin resistance in both yeast and human cells.
  • Targeting the endocytosis pathway may offer strategies to improve adriamycin chemotherapy efficacy.
  • Further research into the endocytosis-adriamycin toxicity relationship is warranted.

More Related Videos

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment04:48

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Published on: January 7, 2015

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.5K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.8K